Bookmark

Add to MyYahoo RSS

Hepatitis News

News on Hepatitis continually updated from thousands of sources around the net.

2 hrs ago | BioMed Central

Hepatitis B spliced protein (HBSP) promotes the carcinogenic effects...

The risk of hepatocellular carcinoma increases in chronic hepatitis B surface antigen carriers who often have concomitant increase in the levels of benzo[alpha]pyrene-7,8-diol-9,10-epoxide -DNA adduct in liver tissues, suggesting a possible co-carcinogenesis of Hepatitis B virus and benzo[alpha]pyrene in HCC; however the exact mechanisms involved ... (more)

Comment?

Related Topix: Medicine, Health

6 hrs ago | Aidsmap

Sofosbuvir for hepatitis C works well despite multiple negative predictive factors

Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.

Comment?

Related Topix: Medicine, Health, Genetics

7 hrs ago | Customer Interaction Solutions

Research and Markets: Global Hepatitis C Therapeutics in Major Developed Markets 2013-2019

The global market has the potential to grow to a value of $18.6 billion by 2019, more than tripling the 2012 market value of $5.8 billion Hepatitis C Therapeutics in Major Developed Markets to 2019 - Outstanding Recent Approvals and Late-Stage Pipeline to Transform Clinical and Commercial Landscape.

Comment?

Related Topix: Medicine, Health

9 hrs ago | South Florida Blade

Need Wood: Is Size King?

I keep getting all this spam for penis enlargement creams and pills in my email box.

Comment?

Related Topix: Email Spam, Medicine

Tue Apr 22, 2014

Seeking Alpha

Gilead Sciences' CEO Discusses Q1 2014 Results - Earnings Call Transcript

Welcome to the Gilead Sciences' first quarter 2014 earnings conference call. I would now like to turn the call over to Patrick O'Brien, Vice President of Investor Relations.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Startups, Health, Marketing

Daily Monitor

Government needs Shs75b for Hepatitis B fight, says minister

Ms Sarah Opendi, the state minister for health, said the money is required for purchase of drugs for treatment and vaccines for the next two years.

Comment?

Related Topix: Medicine, Health

BioMed Central

Prevalence and trends of markers of hepatitis B virus, hepatitis C...

Diego M Flichman , Jorgelina L Blejer , Beatriz I Livellara , Viviana E Re , Sonia Bartoli , Juan A Bustos , Claudia P Ansola , Susana Hidalgo , Martin E Cerda , Alicia E Levin , Adriana Huenul , Victoria Riboldi , Elena MC Trevino , Horacio J Salamone , Felix A Nunez , Robert J Fernandez , Juan F Reybaud and Rodolfo H Campos ... (more)

Comment?

Related Topix: Medicine, Health

The Chronicle Herald

Mike MacDonald seriously funny

Ottawa-based comedian Mike MacDonald makes his first Ha!ifax Comedy Fest appearance at the opening gala Wednesday night at Casino Nova Scotia.

Comment?

Related Topix: Medicine, Health, Canada, World News, Reality TV, Entertainment, Television

Fox News

Gilead Profit Triples On Hepatitis C Drug Revenue

Gilead Sciences Inc , which ignited a fierce debate over prescription drug prices, said its new $1,000 hepatitis C pill generated quarterly sales of $2.27 billion, helping the company's quarterly net profit nearly triple.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Health, Startups, Business News

MarketWatch

Gilead shares climb; AT&T, Amgen shares fall

Gilead Sciences Inc., AT&T Inc. and Amgen Inc. were among the stocks actively trading Tuesday evening, with shares of Gilead climbing after handily beating Wall Street's quarterly earnings and revenue expectations and reporting a sales surge for its new hepatitis C treatment.

Comment?

Related Topix: Biotech, Medicine, Amgen, Healthcare Industry, Gilead Sciences, Cable & Satellite, Telecom, ATT, Startups, Financial Markets, Health

MarketWatch

Should doctors care what treatments cost?

When a particularly effective medical treatment also turns out to be particularly expensive, it creates a quandary for the insurers and patients who foot the bill.

Comment?

Related Topix: Medicine, Cardiology, Oncology

GastroHep.com

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

This week's issue of the New England Journal of Medicine evaluates the use of ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.

Comment?

Related Topix: Medicine, Health

Freshnews

Enanta Pharmaceuticals Announces New Drug Application Submission to...

Enanta Pharmaceuticals, Inc. , a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that AbbVie, Enanta's collaboration partner for ABT-450, has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for an ... (more)

Comment?

Related Topix: Infectious Diseases, Medicine, Food and Drug Administration, Health, Norvir, Ritonavir (generic)

News 4 Jax

Wiping out hepatitis C

Warmuth had some tough times to get through; 17 years ago he was diagnosed with hepatitis C, a virus that attacks the liver.

Comment?

Related Topix: Medicine, Health

Lincoln Daily News

Biogen prices hemophilia drug on par with older therapies

B iogen Idec Inc is pricing its newly approved long-acting hemophilia drug, Alprolix, to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.

Comment?

Related Topix: Hemophilia, Health, Pfizer, Biotech, Medicine, Healthcare Industry, Gilead Sciences, Genetics

Mon Apr 21, 2014

Northwest Herald

Health Dept. offers communicable disease testing

Woodstock Ill. – In recognition of April's National Public Health Week, the McHenry County Department of Health is offering free confidential or anonymous rapid HIV testing, by appointment, for individuals at high risk for infection.

Comment?

Related Topix: HIV/AIDS, Health, Woodstock, IL, Centers for Disease Control and Prevention, Biotech, Medicine, Healthcare Industry

Canada.com

Drugs to cure hepatitis C coming soon, but can we afford them?

Dr. Curtis Cooper, the director of The Ottawa Hospital and Regional Hepatitis Program, says pharmaceutical companies and governments need to work together to make the new treatments for hepatitis C widely available.

Comment?

Related Topix: Medicine, Biotech, Gilead Sciences, Healthcare Industry

PhysOrg Weblog

Scientists make critical end-stage liver discovery

A team of researchers in the University of Arizona's College of Pharmacy has discovered a molecular pathway that could be key to creating new therapeutics that would slow or even reverse the progression of end-stage liver disease.

Comment?

Related Topix: Medicine, Biology, Science, Pharmacology

Mashable

First Scenes Revealed From 'True Blood' Season 7: 'There's No One Left'

HBO is giving True Blood fans their first glimpse of the series' final season in a new video teaser that brings viewers deeper into the aftermath of season six's Hepatitis V virus.

Comment?

Related Topix: True Blood, Entertainment, Television, Vampire News, Medicine, Health

Seeking Alpha

3 Stocks To Capitalize On Advances In Hepatitis C Treatment

There has recently been a spate of announcements in the hepatitis C treatment space and doctors have generally welcomed the entry of more drugs to provide more treatment options.

Comment?

Related Topix: Medicine, Health, Financial Markets, Biotech, Gilead Sciences, Healthcare Industry, Healthcare Law, Law, Merck , Bristol Myers Squibb

•••
•••
•••
•••
•••
•••
•••
•••
•••